Trade-Ideas LLC identified Cempra (CEMP) as a "perilous reversal" (up big yesterday but down big today) candidate ...

Shares of Cempra, Inc. CEMP plunged 57.3% after the company announced that it received a Complete Response Letter (CRL) from the FDA relating to the company’s new drug applications (NDAs) for ...

Cempra Inc (NASDAQ:CEMP) is one to watch going forward, with a busy fourth quarter on the cards. Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT) Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT) or.

Cempra Inc (NASDAQ:CEMP) has experienced an increase in support from the world’s most successful money managers of late. CEMP was in 15 hedge funds’ portfolios at the end of September.

ADVISORY, Jan. 27, 2016 (GLOBE NEWSWIRE) -- What: Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the ...